XSHE
000423
Market cap4.75bUSD
Jun 16, Last price
52.94CNY
1D
-1.74%
1Q
-9.13%
Jan 2017
-1.73%
Name
Dong-E-E-Jiao Co Ltd
Chart & Performance
Profile
Dong-E-E-Jiao Co.,Ltd. produces and sells traditional Chinese medicines, biological drugs, and health food products in China. Dong-E-E-Jiao Co.,Ltd. was founded in 1952 and is based in Liaocheng, China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | ||||||||||
Revenues | 5,920,786 25.57% | 4,715,266 16.66% | 4,041,818 5.01% | |||||||
Cost of revenue | 3,529,795 | 3,120,865 | 2,795,800 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 2,390,991 | 1,594,401 | 1,246,018 | |||||||
NOPBT Margin | 40.38% | 33.81% | 30.83% | |||||||
Operating Taxes | 298,819 | 210,945 | 132,788 | |||||||
Tax Rate | 12.50% | 13.23% | 10.66% | |||||||
NOPAT | 2,092,172 | 1,383,456 | 1,113,231 | |||||||
Net income | 1,557,001 35.29% | 1,150,879 47.55% | 779,998 77.10% | |||||||
Dividends | (758,665) | (425,114) | ||||||||
Dividend yield | 2.39% | 1.62% | ||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 24,029 | |||||||||
Long-term debt | 41,902 | 62,046 | 84,889 | |||||||
Deferred revenue | 58,952 | 65,741 | 75,838 | |||||||
Other long-term liabilities | 63,925 | 57,347 | 57,954 | |||||||
Net debt | (5,057,493) | (5,849,158) | (7,121,891) | |||||||
Cash flow | ||||||||||
Cash from operating activities | 2,170,810 | 1,953,438 | 2,144,878 | |||||||
CAPEX | (54,450) | |||||||||
Cash from investing activities | (718,144) | 589,508 | ||||||||
Cash from financing activities | (778,982) | |||||||||
FCF | 2,137,235 | 1,995,602 | 2,236,353 | |||||||
Balance | ||||||||||
Cash | 8,534,124 | 8,336,771 | 7,230,809 | |||||||
Long term investments | (3,434,728) | (2,425,568) | ||||||||
Excess cash | 4,803,356 | 5,675,441 | 7,028,718 | |||||||
Stockholders' equity | 9,548,275 | 9,874,090 | 10,002,832 | |||||||
Invested Capital | 5,672,364 | 5,219,233 | 3,354,216 | |||||||
ROIC | 38.42% | 32.27% | 28.35% | |||||||
ROCE | 22.82% | 14.63% | 12.00% | |||||||
EV | ||||||||||
Common stock shares outstanding | 643,389 | 642,949 | 643,977 | |||||||
Price | 62.72 27.17% | 49.32 21.18% | 40.70 -16.51% | |||||||
Market cap | 40,353,342 27.26% | 31,710,240 20.99% | 26,209,857 -16.51% | |||||||
EV | 35,317,568 | 25,882,630 | 19,109,513 | |||||||
EBITDA | 2,544,172 | 1,758,246 | 1,413,253 | |||||||
EV/EBITDA | 13.88 | 14.72 | 13.52 | |||||||
Interest | 7,639 | 3,973 | 5,177 | |||||||
Interest/NOPBT | 0.32% | 0.25% | 0.42% |